The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022

M. Ducreux; G. K. Abou-Alfa; T. Bekaii-Saab; J. Berlin; A. Cervantes; T. de Baere; C. Eng; P. Galle; S. Gill; T. Gruenberger; K. Haustermans; A. Lamarca; P. Laurent-Puig; J. M. Llovet; F. Lordick; T. Macarulla; D. Mukherji; K. Muro; R. Obermannova; J. M. O'Connor; E. M. O'Reilly; P. Osterlund; P. Philip; G. Prager; E. Ruiz-Garcia; B. Sangro; T. Seufferlein; J. Tabernero; C. Verslype; H. Wasan; E. Van Cutsem

doi:10.1016/j.esmoop.2023.101567

The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022

M. Ducreux, G. K. Abou-Alfa, T. Bekaii-Saab, J. Berlin, A. Cervantes, T. de Baere, C. Eng, P. Galle, S. Gill, T. Gruenberger, K. Haustermans, A. Lamarca, P. Laurent-Puig, J. M. Llovet, F. Lordick, T. Macarulla, D. Mukherji, K. Muro, R. Obermannova, J. M. O'ConnorE. M. O'Reilly, P. Osterlund, P. Philip, G. Prager, E. Ruiz-Garcia, B. Sangro, T. Seufferlein, J. Tabernero, C. Verslype, H. Wasan, E. Van Cutsem

Hematology/Oncology

Research output: Contribution to journal › Review article › peer-review

Abstract

This article summarises expert discussion on the management of patients with hepatocellular carcinoma (HCC), which took place during the 24th World Gastrointestinal Cancer Congress (WGICC) in Barcelona, July 2022. A multidisciplinary approach is mandatory to ensure an optimal diagnosis and staging of HCC, planning of curative and therapeutic options, including surgical, embolisation, ablative strategies, or systemic therapy. Furthermore, in many patients with HCC, underlying liver cirrhosis represents a challenge and influences the therapeutic options.

Original language	English (US)
Article number	101567
Journal	ESMO Open
Volume	8
Issue number	3
DOIs	https://doi.org/10.1016/j.esmoop.2023.101567
State	Published - Jun 2023

Keywords

chemoembolisation
hepatocellular carcinoma
immunotherapy
liver transplantation
radioembolisation

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1016/j.esmoop.2023.101567

Cite this

Ducreux, M., Abou-Alfa, G. K., Bekaii-Saab, T., Berlin, J., Cervantes, A., de Baere, T., Eng, C., Galle, P., Gill, S., Gruenberger, T., Haustermans, K., Lamarca, A., Laurent-Puig, P., Llovet, J. M., Lordick, F., Macarulla, T., Mukherji, D., Muro, K., Obermannova, R., ... Van Cutsem, E. (2023). The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022. ESMO Open, 8(3), Article 101567. https://doi.org/10.1016/j.esmoop.2023.101567

Ducreux, M, Abou-Alfa, GK, Bekaii-Saab, T, Berlin, J, Cervantes, A, de Baere, T, Eng, C, Galle, P, Gill, S, Gruenberger, T, Haustermans, K, Lamarca, A, Laurent-Puig, P, Llovet, JM, Lordick, F, Macarulla, T, Mukherji, D, Muro, K, Obermannova, R, O'Connor, JM, O'Reilly, EM, Osterlund, P, Philip, P, Prager, G, Ruiz-Garcia, E, Sangro, B, Seufferlein, T, Tabernero, J, Verslype, C, Wasan, H & Van Cutsem, E 2023, 'The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022', ESMO Open, vol. 8, no. 3, 101567. https://doi.org/10.1016/j.esmoop.2023.101567

@article{c139a018d7e649cea2f7b46db8a76636,

title = "The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022",

abstract = "This article summarises expert discussion on the management of patients with hepatocellular carcinoma (HCC), which took place during the 24th World Gastrointestinal Cancer Congress (WGICC) in Barcelona, July 2022. A multidisciplinary approach is mandatory to ensure an optimal diagnosis and staging of HCC, planning of curative and therapeutic options, including surgical, embolisation, ablative strategies, or systemic therapy. Furthermore, in many patients with HCC, underlying liver cirrhosis represents a challenge and influences the therapeutic options.",

keywords = "chemoembolisation, hepatocellular carcinoma, immunotherapy, liver transplantation, radioembolisation",

author = "M. Ducreux and Abou-Alfa, {G. K.} and T. Bekaii-Saab and J. Berlin and A. Cervantes and {de Baere}, T. and C. Eng and P. Galle and S. Gill and T. Gruenberger and K. Haustermans and A. Lamarca and P. Laurent-Puig and Llovet, {J. M.} and F. Lordick and T. Macarulla and D. Mukherji and K. Muro and R. Obermannova and O'Connor, {J. M.} and O'Reilly, {E. M.} and P. Osterlund and P. Philip and G. Prager and E. Ruiz-Garcia and B. Sangro and T. Seufferlein and J. Tabernero and C. Verslype and H. Wasan and {Van Cutsem}, E.",

note = "Publisher Copyright: {\textcopyright} 2023 The Author(s)",

year = "2023",

month = jun,

doi = "10.1016/j.esmoop.2023.101567",

language = "English (US)",

volume = "8",

journal = "ESMO Open",

issn = "2059-7029",

publisher = "BMJ Publishing Group",

number = "3",

}

TY - JOUR

T1 - The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022

AU - Ducreux, M.

AU - Abou-Alfa, G. K.

AU - Bekaii-Saab, T.

AU - Berlin, J.

AU - Cervantes, A.

AU - de Baere, T.

AU - Eng, C.

AU - Galle, P.

AU - Gill, S.

AU - Gruenberger, T.

AU - Haustermans, K.

AU - Lamarca, A.

AU - Laurent-Puig, P.

AU - Llovet, J. M.

AU - Lordick, F.

AU - Macarulla, T.

AU - Mukherji, D.

AU - Muro, K.

AU - Obermannova, R.

AU - O'Connor, J. M.

AU - O'Reilly, E. M.

AU - Osterlund, P.

AU - Philip, P.

AU - Prager, G.

AU - Ruiz-Garcia, E.

AU - Sangro, B.

AU - Seufferlein, T.

AU - Tabernero, J.

AU - Verslype, C.

AU - Wasan, H.

AU - Van Cutsem, E.

PY - 2023/6

Y1 - 2023/6

N2 - This article summarises expert discussion on the management of patients with hepatocellular carcinoma (HCC), which took place during the 24th World Gastrointestinal Cancer Congress (WGICC) in Barcelona, July 2022. A multidisciplinary approach is mandatory to ensure an optimal diagnosis and staging of HCC, planning of curative and therapeutic options, including surgical, embolisation, ablative strategies, or systemic therapy. Furthermore, in many patients with HCC, underlying liver cirrhosis represents a challenge and influences the therapeutic options.

AB - This article summarises expert discussion on the management of patients with hepatocellular carcinoma (HCC), which took place during the 24th World Gastrointestinal Cancer Congress (WGICC) in Barcelona, July 2022. A multidisciplinary approach is mandatory to ensure an optimal diagnosis and staging of HCC, planning of curative and therapeutic options, including surgical, embolisation, ablative strategies, or systemic therapy. Furthermore, in many patients with HCC, underlying liver cirrhosis represents a challenge and influences the therapeutic options.

KW - chemoembolisation

KW - hepatocellular carcinoma

KW - immunotherapy

KW - liver transplantation

KW - radioembolisation

UR - http://www.scopus.com/inward/record.url?scp=85160563203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85160563203&partnerID=8YFLogxK

U2 - 10.1016/j.esmoop.2023.101567

DO - 10.1016/j.esmoop.2023.101567

M3 - Review article

C2 - 37263081

AN - SCOPUS:85160563203

SN - 2059-7029

VL - 8

JO - ESMO Open

JF - ESMO Open

IS - 3

M1 - 101567

ER -

The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this